RPS Receives CLIA Waiver for New AdenoPlus™
The U.S. Food and Drug Administration (FDA) announced today that AdenoPlus™ – an improved version of Rapid Pathogen Screening’s (RPS®) first point-of-care (POC) diagnostic test for conjunctivitis...
(PRWeb April 26, 2012)
Read the full story at http://www.prweb.com/releases/2012/4/prweb9441098.htm
Comments are closed.